Related Experiment Video
Updated: Apr 1, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Patent Foramen Ovale and Stroke-Current Status
Oh Young Bang1, Mi Ji Lee1, Sookyung Ryoo1
1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Patent foramen ovale (PFO) closure shows no superiority over medical treatment for embolic stroke of undetermined source (ESUS). Alternative stroke mechanisms in PFO patients warrant further investigation.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Patent foramen ovale (PFO) is increasingly recognized in embolic stroke of undetermined source (ESUS).
- Advances in diagnosis and device closure have heightened clinical interest in PFO.
- Recent trials question the efficacy of PFO closure for ESUS.
Purpose of the Study:
- To review the current understanding of stroke pathophysiology in patients with PFO and ESUS.
- To explore therapeutic options for PFO-associated ESUS.
Main Methods:
- Literature review of recent randomized controlled trials.
- Analysis of PFO diagnosis and treatment advancements.
- Discussion of stroke mechanisms beyond paradoxical embolism.
Main Results:
- Randomized trials failed to show PFO closure superiority over medical management for ESUS.
- The role of paradoxical embolism as the sole stroke mechanism is debated.
- Alternative stroke etiologies are likely significant in ESUS patients with PFO.
Conclusions:
- PFO closure may not be superior to medical therapy for all ESUS patients.
- Understanding non-embolic stroke mechanisms in PFO patients is crucial.
- Further research is needed to refine therapeutic strategies for ESUS and PFO.
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Mitral Stenosis II: Clinical features and Diagnostic Tests

